Search
for
Sort by
Research 541–570 of 1000+
- Repurposing of approved cardiovascular drugs
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- GENETIC CONTROL OF CYTOKINES
- Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers
- Diagnosis, Pathogenesis and Management of Polycystic Ovary Syndrome
- Multi-omics analysis unveils the role of cancer-associated fibroblasts in cutaneous squamous cell carcinoma
- The Role of LncRNAs in Radio- and Chemoresistance of Glioblastoma: Prognostic or Therapeutic?
- Abstracts from the 2024 WDS Forum - virtual option
- Recent Advances in Microneedling-Assisted Cosmetic Applications
- Triton modified polyethyleneimine conjugates assembled with growth arrest-specific protein 6 for androgenetic alopecia transdermal gene therapy
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- Inorganic Nanozymes: Prospects for Disease Treatments and Detection Applications
- Tuning Scaffold Properties of New 1,4-Substituted Pyrrolo[3,2-c]quinoline Derivatives Endowed with Anticancer Potential, New Biological and In Silico Insights
- Calcipotriene/betamethasone in the treatment of psoriasis: a review article
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Epigenetics of Colorectal Cancer
- Dissecting the Impact of Chemotherapy on the Human Hair Follicle
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Current management strategies for cutaneous T-cell lymphoma
- Transglutaminase 3: The Involvement in Epithelial Differentiation and Cancer
- Emerging Therapies for Acne Vulgaris
- Responsive Microneedles as a New Platform for Precision Immunotherapy
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- TLRgeting Evasion of Immune Pathways in Glioblastoma
- Radiation- and Chemotherapy-Induced Permanent Alopecia: Case Series
- Clinical Development of Topoisomerase-Interactive Drugs
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- GSDMA deficiency impairs cutaneous squamous cell carcinoma growth
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy